top of page
  • LinkedIn
  • Facebook
  • Twitter

The Lancet Journal - Efficacy and safety of phospholipid nanoparticles (VBI-S) in reversing intractable hypotension in patients with septic shock: a multicentre, open-label, repeated measures, phase 2

Updated: Feb 5








Vivacelle Bio Feature in the Lancet Journal
.pdf
Download PDF • 421KB

bottom of page